Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Director/PDMR Shareholding

30 Jun 2006 08:55

Halma PLC30 June 2006 HALMA p.l.c. DIRECTORS and PDMRs INCREASE SHAREHOLDINGS At a Meeting of the Share Plans Committee of the Board of Halma p.l.c. held on29 June 2006, a total of 414,730 additional ordinary shares in the Company wereallotted under the provisions of the Company's Share Option Schemes to Directorsand PDMRs of the Company, following the exercise of share options, as set outbelow. Following the execution of the net transactions noted below, the totalshareholdings of the Directors and PDMRs increased by 126,624 shares. Andrew Williams, Director 17,500 shares were allotted to Andrew Williams at an exercise price of 163.50pper share. In addition to the 17,500 shares allotted above, the Company has receivednotification that Andrew Williams purchased 18,480 shares in the Company at195.5p per share on 29 June 2006. After the above transactions, the beneficial holding of Andrew Williams in theordinary shares of Halma p.l.c. increases by 35,980 shares to 72,473 shares(0.02% of the issued ordinary share capital). Kevin Thompson, Director 99,932 shares were allotted to Kevin Thompson. The exercise prices were as follows: No of shares Price per share 15,466 138.01p 19,066 138.00p 65,400 122.50p To finance the exercise of these share options and the associated tax liability,Kevin Thompson sold 72,972 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Kevin Thompson,including family interests, in the ordinary shares of Halma p.l.c. increases by26,960 shares to 99,609 shares (0.027% of the issued ordinary share capital). Neil Quinn, Director 203,466 ordinary shares were allotted to Neil Quinn. The exercise prices were as follows: No of shares Price per share 19,066 138.00p 84,400 122.50p 100,000 116.50p To finance the exercise of these share options and the associated tax liability,Neil Quinn sold 184,400 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Neil Quinn in theordinary shares of Halma p.l.c. increases by 19,066 shares to 69,118 shares(0.019% of the issued ordinary share capital). Keith Roy, Director 43,066 shares were allotted to Keith Roy at an exercise price of 139.50p per share. To finance the exercise of these share options and the associated tax liability,Keith Roy sold 30,953 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Keith Roy, includingfamily interests, in the ordinary shares of Halma p.l.c. increases by 12,113shares to 760,649 shares (0.206% of the issued ordinary share capital). Nigel Young, PDMR 19,066 shares were allotted to Nigel Young at an exercise price of 138.00p pershare. To finance the exercise of these share options and the associated tax liability,Nigel Young sold 13,557 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Nigel Young, includingfamily interests, in the ordinary shares of Halma p.l.c. increases by 5,509shares to 34,932 shares (0.009% of the issued ordinary share capital). Adam Meyers, PDMR 20,000 shares were allotted to Adam Meyers at an exercise price of 122.50p pershare. Adam Meyers' existing beneficial interest in the ordinary shares of the Companyis held through the Halma Holdings Inc. Profit Sharing Savings Retirement Plan.Due to the unitised nature of the retirement plan and fluctuations in exchangerates, the precise number of ordinary shares in Halma p.l.c. in which AdamMeyers is interested may fluctuate. After the above transaction, the beneficialholding of Adam Meyers in the ordinary shares of Halma p.l.c. as at 29 June 2006increases by 20,000 shares to 24,367 shares (0.007% of the issued ordinary sharecapital). Carol Chesney, PDMR 11,700 shares were allotted to Carol Chesney at an exercise price of 163.50p pershare. To finance the exercise of these share options and the associated tax liability,Carol Chesney sold 4,704 shares on 29 June 2006 at 194.625p per share. After the above transactions, the beneficial holding of Carol Chesney in theordinary shares of Halma p.l.c. increases by 6,996 shares to 7,384 shares(0.002% of the issued ordinary share capital). Issued ordinary share capital Following the issue of ordinary shares as a result of the share optionsexercised on 29 June 2006, the issued ordinary share capital of the Company isincreased to 369,956,928 shares. Contact for further information: Andrew Williams Chief Executive, Halma p.l.c. Tel: +44 (0)1494 721111 A copy of this announcement, together with other information about Halma, may beviewed on its website: www.halma.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.